This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2021 Apr 7;11(1):8015.

doi: 10.1038/s41598-021-87190-2.

Author Correction: Establishment, optimisation and quantitation of a bioluminescent murine infection model of visceral leishmaniasis for systematic vaccine screening

Han Boon Ong¹, Simon Clare², Adam Jonathan Roberts¹, Mary Edythe Wilson³, Gavin James Wright⁴

Affiliations

Affiliations

¹ Cell Surface Signalling Laboratory, Wellcome Sanger Institute, Cambridge, UK.
² Pathogen Laboratory Support, Wellcome Sanger Institute, Cambridge, UK.
³ Departments of Microbiology and Immunology and Internal Medicine, University of Iowa, Iowa City Veterans' Affairs Medical Center, Iowa City, USA.
⁴ Cell Surface Signalling Laboratory, Wellcome Sanger Institute, Cambridge, UK. gw2@sanger.ac.uk.

PMID: 33828148
PMCID: PMC8027875
DOI: 10.1038/s41598-021-87190-2

Published Erratum

Author Correction: Establishment, optimisation and quantitation of a bioluminescent murine infection model of visceral leishmaniasis for systematic vaccine screening

Han Boon Ong et al. Sci Rep. 2021.

. 2021 Apr 7;11(1):8015.

doi: 10.1038/s41598-021-87190-2.

Authors

Han Boon Ong¹, Simon Clare², Adam Jonathan Roberts¹, Mary Edythe Wilson³, Gavin James Wright⁴

Affiliations

¹ Cell Surface Signalling Laboratory, Wellcome Sanger Institute, Cambridge, UK.
² Pathogen Laboratory Support, Wellcome Sanger Institute, Cambridge, UK.
³ Departments of Microbiology and Immunology and Internal Medicine, University of Iowa, Iowa City Veterans' Affairs Medical Center, Iowa City, USA.
⁴ Cell Surface Signalling Laboratory, Wellcome Sanger Institute, Cambridge, UK. gw2@sanger.ac.uk.

PMID: 33828148
PMCID: PMC8027875
DOI: 10.1038/s41598-021-87190-2

No abstract available

PubMed Disclaimer

Erratum for

Establishment, optimisation and quantitation of a bioluminescent murine infection model of visceral leishmaniasis for systematic vaccine screening.
Ong HB, Clare S, Roberts AJ, Wilson ME, Wright GJ. Ong HB, et al. Sci Rep. 2020 Mar 13;10(1):4689. doi: 10.1038/s41598-020-61662-3. Sci Rep. 2020. PMID: 32170135 Free PMC article.

Similar articles

Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis.
Aguilar-Be I, da Silva Zardo R, Paraguai de Souza E, Borja-Cabrera GP, Rosado-Vallado M, Mut-Martin M, García-Miss Mdel R, Palatnik de Sousa CB, Dumonteil E. Aguilar-Be I, et al. Infect Immun. 2005 Feb;73(2):812-9. doi: 10.1128/IAI.73.2.812-819.2005. Infect Immun. 2005. PMID: 15664920 Free PMC article.
Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL, Holzmuller P, Gonçalves RB, Bourdoiseau G, Hugnet C, Cavaleyra M, Papierok G. Lemesre JL, et al. Vaccine. 2007 May 22;25(21):4223-34. doi: 10.1016/j.vaccine.2007.02.083. Epub 2007 Mar 15. Vaccine. 2007. PMID: 17395339 Clinical Trial.
Enhanced efficacy and immunogenicity of 78kDa antigen formulated in various adjuvants against murine visceral leishmaniasis.
Nagill R, Kaur S. Nagill R, et al. Vaccine. 2010 May 21;28(23):4002-12. doi: 10.1016/j.vaccine.2010.01.015. Epub 2010 Jan 19. Vaccine. 2010. PMID: 20093205
Vaccines for visceral leishmaniasis: A review.
Jain K, Jain NK. Jain K, et al. J Immunol Methods. 2015 Jul;422:1-12. doi: 10.1016/j.jim.2015.03.017. Epub 2015 Apr 7. J Immunol Methods. 2015. PMID: 25858230 Review.
Progress in vaccine research and possible effector mechanisms in visceral leishmaniasis.
Ravindran R, Ali N. Ravindran R, et al. Curr Mol Med. 2004 Sep;4(6):697-709. doi: 10.2174/1566524043360212. Curr Mol Med. 2004. PMID: 15357218 Review.

See all similar articles

Publication types

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations